Certified by Founder Lodge
Osage University Partners (OUP)
United States - Bala Cynwyd, PA
INVESTOR
1 Disclosed Funding Rounds $55,000,000
50 Participating Investments
-
Operating Status
Active
-
Last Funding Type
Seed
-
Company Type
For Profit
- Website
- Contact
- Social Links
Osage University Partners (OUP) is a venture capital fund that invests exclusively in startups that are commercializing university research. OUP firmly believes that universities provide an
| Company | Date | Round | Raised |
|---|---|---|---|
 AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
 Kate Therapeutics |
June, 08 ,2023 | Series A | $51,000,000 |
 Quintessent Inc. |
March, 15 ,2024 | Seed | $11,500,000 |
| Quintessent Inc. |
March, 15 ,2024 | Seed | $11,500,000 |
 Brimstone |
May, 05 ,2022 | Series A | $55,000,000 |
 ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
 Hack The Box |
January, 11 ,2023 | Unknown | $55,000,000 |
 Veradermics |
December, 12 ,2024 | Series B | $75,000,000 |
 Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
 Delfi Diagnostics |
July, 18 ,2022 | Series B | $225,000,000 |
| Veradermics |
December, 12 ,2024 | Series B | $75,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
 SiFive |
March, 16 ,2022 | Series F | $175,000,000 |
 MicroTransponder |
March, 18 ,2025 | Series F | $65,000,000 |
| Quintessent Inc. |
March, 15 ,2024 | Seed | $11,500,000 |
| MicroTransponder |
March, 18 ,2025 | Series F | $65,000,000 |
| Brimstone |
May, 05 ,2022 | Series A | $55,000,000 |
 Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Kate Therapeutics |
June, 08 ,2023 | Series A | $51,000,000 |
| Veradermics |
December, 12 ,2024 | Series B | $75,000,000 |
 Addition Therapeutics |
December, 18 ,2025 | Unknown | $100,000,000 |
| Veradermics |
December, 12 ,2024 | Series B | $75,000,000 |
| ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
| SiFive |
March, 16 ,2022 | Series F | $175,000,000 |
| Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
| MicroTransponder |
March, 18 ,2025 | Series F | $65,000,000 |
| Quintessent Inc. |
March, 15 ,2024 | Seed | $11,500,000 |
| MicroTransponder |
March, 18 ,2025 | Series F | $65,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Veradermics |
December, 12 ,2024 | Series B | $75,000,000 |
| Kate Therapeutics |
June, 08 ,2023 | Series A | $51,000,000 |
| MicroTransponder |
March, 18 ,2025 | Series F | $65,000,000 |
| Addition Therapeutics |
December, 18 ,2025 | Unknown | $100,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| ReCode Therapeutics |
September, 20 ,2023 | Series B | $50,000,000 |
| Addition Therapeutics |
December, 18 ,2025 | Unknown | $100,000,000 |
| Nocion Therapeutics, Inc. |
March, 06 ,2024 | Series B | $62,000,000 |
 Terremoto Biosciences |
April, 16 ,2026 | Series C | $108,000,000 |
| Quintessent Inc. |
March, 15 ,2024 | Seed | $11,500,000 |
 Tessera Labs |
May, 07 ,2026 | Unknown | $60,000,000 |
| AssetWatch® |
May, 21 ,2024 | Series B | $38,000,000 |
| Veradermics |
December, 12 ,2024 | Series B | $75,000,000 |
| MicroTransponder |
March, 18 ,2025 | Series F | $65,000,000 |
| Atsena Therapeutics |
April, 07 ,2025 | Series C | $150,000,000 |
| Addition Therapeutics |
December, 18 ,2025 | Unknown | $100,000,000 |
| Terremoto Biosciences |
April, 16 ,2026 | Series C | $108,000,000 |
| Tessera Labs |
May, 07 ,2026 | Unknown | $60,000,000 |
Cherry Ventures
Blue Bear Capital
Slow Ventures
Climate Capital
Eniac Ventures
Ranger AI | $8,400,000 | (May 15, 2026)
Graphon AI | $8,300,000 | (May 15, 2026)
Iceotope | $26,000,000 | (May 15, 2026)
Wirestock | $23,000,000 | (May 15, 2026)
Chromie Health | $2,000,000 | (May 15, 2026)
